Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J. Hogg, Ricky W. Johnstone, Robert M. Myers et al.|Molecular Cell|2021Cited by 167
The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shockAlison C. West, Jake Shortt|Oncogenesis|2016Cited by 32
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H. Oh, Jake Shortt|Proceedings of the National Academy of Sciences|2023Cited by 9